India, Liberia Inks MoU to Improve Medicine Quality Standards

India and Liberia have formalised cooperation in the field of pharmacopoeia through a new Memorandum of Understanding aimed at strengthening regulatory alignment and advancing shared health objectives.  

The agreement marks an important step in deepening bilateral health partnerships and improving access to quality-assured medicines. 

Agreement Signed to Align Drug Standards 

The MoU was signed in Monrovia by India’s Ambassador to Liberia, Manoj Bihari Verma, and Liberia’s Minister of Health, Louise M Kpoto. The Ministry of Health said the objective is to promote shared quality benchmarks and support broader global health collaboration between the 2 countries. 

In an official post on X, the ministry stated: "Strengthening global health cooperation: India and Liberia today signed an MoU on pharmacopoeia to promote shared quality standards and regulatory alignment. The agreement, signed by His excellency Ambassador Manoj Bihari Verma and Health Minister Dr. Louise M Kpoto, will support improved access to safe and affordable medicines. A boost to India-Liberia partnership." 

Regulatory Cooperation and Technical Framework 

According to the Ministry of AYUSH, pharmacopoeias are official compendia that define quality standards for drugs manufactured, imported or distributed within India.  

These standards ensure identity, purity and strength through detailed botanical identification, physico-chemical parameters and specialised analytical techniques such as HPTLC, HPLC, GC, UV-Visible spectrophotometry, AAS and ICP-AES/ICP-MS. 

They also specify limits on heavy metals, pesticide residues, aflatoxins and microbial contamination, forming the backbone of medicine quality assurance systems. 

Read More: India Launches Its First Home-Built Hydrogen Fuel Cell Passenger Vessel in Varanasi! 

Conclusion 

The MoU represents a significant advancement in India-Liberia health cooperation. By enabling the use of Indian pharmacopoeial standards, the agreement is expected to strengthen Liberia’s regulatory systems and expand access to safe and affordable medicines, while reinforcing India’s role as a partner in global health capability building. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.